Daily Signals
2481 companies scored · 2026-10-14 run in progress: 3770 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D
Distribution of the day's forecasts
30D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
287 companies
Sorted by market cap ↓ · forecast rankings are part of the paid plans
| Ticker | Rating | 30D | Δ | |
|---|---|---|---|---|
| SRRKScholar Rock Holding Corp | Unlock rating and forecasts | |||
| TVTXTravere Therapeutics, Inc. | Unlock rating and forecasts | |||
| COGTCogent Biosciences, Inc. | +0.18% | · | ||
| AMRNAMARIN CORP PLC\UK | Unlock rating and forecasts | |||
| CRSPCRISPR Therapeutics AG | Unlock rating and forecasts | |||
| GPCRStructure Therapeutics Inc. | Unlock rating and forecasts | |||
| DFTXDefinium Therapeutics, Inc. | Unlock rating and forecasts | |||
| DNTHDianthus Therapeutics, Inc. /DE/ | Unlock rating and forecasts | |||
| INDVIndivior Pharmaceuticals, Inc. | -0.04% | · | ||
| ADPTAdaptive Biotechnologies Corp | Unlock rating and forecasts | |||
| EWTXEdgewise Therapeutics, Inc. | Unlock rating and forecasts | |||
| ABCLAbCellera Biologics Inc. | Unlock rating and forecasts | |||
| RLAYRelay Therapeutics, Inc. | Unlock rating and forecasts | |||
| TNGXTango Therapeutics, Inc. | Unlock rating and forecasts | |||
| TLXTelix Pharmaceuticals Ltd | Unlock rating and forecasts | |||
| OGNOrganon & Co. | Unlock rating and forecasts | |||
| XENEXenon Pharmaceuticals Inc. | Unlock rating and forecasts | |||
| IDYAIDEAYA Biosciences, Inc. | Unlock rating and forecasts | |||
| ARQTArcutis Biotherapeutics, Inc. | +0.19% | · | ||
| ACADACADIA PHARMACEUTICALS INC | Unlock rating and forecasts | |||
| VKTXViking Therapeutics, Inc. | Unlock rating and forecasts | |||
| TARSTarsus Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| AMLXAmylyx Pharmaceuticals, Inc. | Unlock rating and forecasts | |||
| DNLIDenali Therapeutics Inc. | Unlock rating and forecasts | |||
| ELVNEnliven Therapeutics, Inc. | Unlock rating and forecasts | |||
| RCUSArcus Biosciences, Inc. | Unlock rating and forecasts | |||
| DYNDyne Therapeutics, Inc. | Unlock rating and forecasts | |||
| RADXRadiopharm Theranostics Ltd | -0.10% | · | ||
| PGENPRECIGEN, INC. | Unlock rating and forecasts | |||
| DBVTDBV Technologies S.A. | Unlock rating and forecasts | |||
| NEOGNEOGEN CORP | Unlock rating and forecasts | |||
| BEAMBeam Therapeutics Inc. | Unlock rating and forecasts | |||
| LQDALiquidia Corp | Unlock rating and forecasts | |||
| ADMAADMA BIOLOGICS, INC. | Unlock rating and forecasts | |||
| PBHPrestige Consumer Healthcare Inc. | Unlock rating and forecasts | |||
| NRIXNurix Therapeutics, Inc. | -0.05% | · | ||
| CLDXCelldex Therapeutics, Inc. | Unlock rating and forecasts | |||
| BHCBausch Health Companies Inc. | Unlock rating and forecasts | |||
| AUPHAurinia Pharmaceuticals Inc. | -0.10% | · | ||
| HRMYHarmony Biosciences Holdings, Inc. | Unlock rating and forecasts | |||
| PRGOPERRIGO Co plc | Unlock rating and forecasts | |||
| NVAXNOVAVAX INC | Unlock rating and forecasts | |||
| VRDNViridian Therapeutics, Inc.\DE | Unlock rating and forecasts | |||
| VCELVericel Corp | -0.10% | · | ||
| BCRXBIOCRYST PHARMACEUTICALS INC | Unlock rating and forecasts | |||
| IMNMImmunome Inc. | Unlock rating and forecasts | |||
| TRLVTrulieve Cannabis Corp. | Unlock rating and forecasts | |||
| SDGRSchrodinger, Inc. | Unlock rating and forecasts | |||
| VERAVera Therapeutics, Inc. | Unlock rating and forecasts | |||
| LKFTLakefront Biotherapeutics NV | -0.10% | · | ||
By sector
Median 30D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.